Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Prostate cancer (US Trelstar):
- Trelstar 3.75 mg IM q4 weeks
- Trelstar 11.25 mg IM q12 weeks
- Trelstar 22.5 mg IM q24 weeks
- CPP (US Triptodur): 22.5 mg IM every 24 weeks in patients aged ≥2 years.
- Route: Single intramuscular injection in either buttock
- Note: Dosage strengths are not additive and are not interchangeable across products; select based on desired schedule and indication
- Must be administered by a healthcare professional